Manufacturing

How Can Digital Twins Enhance Bioprocessing Controls?
Biotech & Bioprocessing How Can Digital Twins Enhance Bioprocessing Controls?

Effective digital twin architecture requires a robust data layer that synchronizes information from SCADA systems and laboratory information management systems. In the current landscape of 2026, the biopharmaceutical industry has moved decisively beyond traditional static modeling toward dynamic,

Pharma Industry Adapts to Climate Risks for Business Resilience
Management & Regulatory Pharma Industry Adapts to Climate Risks for Business Resilience

The intricate supply chains required to produce life-saving medications now face unprecedented risks from extreme weather events and critical resource scarcity. The global pharmaceutical sector is currently undergoing a fundamental transformation as climate change shifts from a corporate social

Can 40°C Optimize Growth for Avian Cultivated Protein?
Biotech & Bioprocessing Can 40°C Optimize Growth for Avian Cultivated Protein?

While 37 degrees Celsius is the global default for biological research, it may actually induce a state of chronic metabolic sluggishness in chicken muscle cells. The emergence of cellular agriculture marks a pivotal shift in how the world approaches food security and sustainable protein, yet the

Can Malaysia Lead the Future of Regenerative Medicine?
Biotech & Bioprocessing Can Malaysia Lead the Future of Regenerative Medicine?

The development of a connected nationwide ecosystem for cellular therapy is designed to standardize the quality of regenerative care across every Malaysian state. This ambitious shift is currently reshaping the biotechnology sector, where the focus has moved from being a passive consumer of

How Is Bioprocessing Shaping the Future of Manufacturing?
Management & Regulatory How Is Bioprocessing Shaping the Future of Manufacturing?

Modern industrial sectors are witnessing a quiet revolution where microscopic organisms are replacing heavy machinery and toxic solvents in the race for cleaner and more efficient production. Industrial bioprocessing allows for the creation of complex medicines derived from living organisms,

What Is the Future of Synthetic CAR T-Cell Therapies?
Research & Development What Is the Future of Synthetic CAR T-Cell Therapies?

The inherent inefficiencies of the autologous model are tied to a one-batch-per-patient approach that restricts throughput and maintains high market prices for oncology treatments. While Chimeric Antigen Receptor (CAR) T-cell therapies have redefined oncology by providing life-saving results for

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later